150 related articles for article (PubMed ID: 6790991)
1. Predisposition to phenytoin hepatotoxicity assessed in vitro.
Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
[TBL] [Abstract][Full Text] [Related]
2. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
[TBL] [Abstract][Full Text] [Related]
3. In-vitro lymphocyte toxicity to a phenytoin metabolite in phenytoin induced cutaneous adverse drug eruptions.
Dwivedi R; Gogtay N; Kharkar V; Amladi S; Kshirsagar N
Indian J Dermatol Venereol Leprol; 2004; 70(4):217-20. PubMed ID: 17642618
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Shear NH; Spielberg SP
J Clin Invest; 1988 Dec; 82(6):1826-32. PubMed ID: 3198757
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
Gordon GB; Spielberg SP; Blake DA; Balasubramanian V
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2545-8. PubMed ID: 6941308
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant toxicity in vitro: possible role of arene oxides.
Spielberg SP; Gordon GB; Blake DA; Mellits ED; Bross DS
J Pharmacol Exp Ther; 1981 May; 217(2):386-9. PubMed ID: 7229980
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro.
Gerson WT; Fine DG; Spielberg SP; Sensenbrenner LL
Blood; 1983 May; 61(5):889-93. PubMed ID: 6831050
[TBL] [Abstract][Full Text] [Related]
8. Familial occurrence of hypersensitivity to phenytoin.
Gennis MA; Vemuri R; Burns EA; Hill JV; Miller MA; Spielberg SP
Am J Med; 1991 Dec; 91(6):631-4. PubMed ID: 1750433
[TBL] [Abstract][Full Text] [Related]
9. Halothane hepatitis. Detection of a constitutional susceptibility factor.
Farrell G; Prendergast D; Murray M
N Engl J Med; 1985 Nov; 313(21):1310-4. PubMed ID: 4058523
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone.
Yokoi T
Handb Exp Pharmacol; 2010; (196):419-35. PubMed ID: 20020270
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans.
Spielberg SP
Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury. In vitro demonstration of hypersensitivity to both phenytoin and phenobarbital.
Kahn HD; Faguet GB; Agee JF; Middleton HM
Arch Intern Med; 1984 Aug; 144(8):1677-9. PubMed ID: 6466024
[TBL] [Abstract][Full Text] [Related]
13. In vitro analysis of idiosyncratic drug reactions.
Spielberg SP
Clin Biochem; 1986 Apr; 19(2):142-4. PubMed ID: 3708795
[TBL] [Abstract][Full Text] [Related]
14. In-vitro assessment of a hypersensitivity syndrome associated with sorbinil.
Spielberg SP; Shear NH; Cannon M; Hutson NJ; Gunderson K
Ann Intern Med; 1991 May; 114(9):720-4. PubMed ID: 2012352
[TBL] [Abstract][Full Text] [Related]
15. Increased microsomal irreversible binding of phenytoin by valproic acid.
Wang SL; Lai ML; Huang JD
Biochem Pharmacol; 1991 Aug; 42(5):1143-4. PubMed ID: 1872899
[TBL] [Abstract][Full Text] [Related]
16. Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs.
Santos NA; Medina WS; Martins NM; Rodrigues MA; Curti C; Santos AC
Toxicol In Vitro; 2008 Dec; 22(8):1820-4. PubMed ID: 18783732
[TBL] [Abstract][Full Text] [Related]
17. Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.
Martz F; Failinger C; Blake DA
J Pharmacol Exp Ther; 1977 Oct; 203(1):231-9. PubMed ID: 909055
[TBL] [Abstract][Full Text] [Related]
18. Diphenylhydantoin-induced hepatotoxicity.
Aaron JS; Bank S; Ackert G
Am J Gastroenterol; 1985 Mar; 80(3):200-2. PubMed ID: 3976639
[No Abstract] [Full Text] [Related]
19. Phenytoin-induced hypersensitivity reactions.
Prosser TR; Lander RD
Clin Pharm; 1987 Sep; 6(9):728-34. PubMed ID: 3677571
[TBL] [Abstract][Full Text] [Related]
20. Genetic predisposition to phenytoin-induced birth defects.
Strickler SM; Dansky LV; Miller MA; Seni MH; Andermann E; Spielberg SP
Lancet; 1985 Oct; 2(8458):746-9. PubMed ID: 2864485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]